Zerosum™, Inc. is a Pennsylvania USA C Corporation focusing on accelerating the benefits of genetic discoveries and research. Today, the best way to overcome the difficulties associated with advancing genetic solutions to market is to have an infrastructure that does not rely on legacy operational pathways. This infrastructure should be built based on the latest technology and designed with current and future objectives in mind. Advances in the life sciences arena are rapidly overwhelming existing systems and resources. Being in its infancy, the industry offers exciting opportunities but lacks the physical interfaces, global IT infrastructure, and interoperability for providing an effective research-to-market solution.

We believe this problem can be solved, and we are developing the results-to-end user(s) infrastructure required for today's life science advancements. The first step is to create a reliable device interface between the analog world of life sciences and the digital world of information technology. The second step is to connect that conversion interface to our secure BioIT network infrastructure, enabling access, storage, and processing directly to the customer.

Current development is focused on the physical device containing the electronic/diagnostic interface(s). Our interface(s) are designed to be hand-held, field portable, and capable of converting results from our SNP detection module/device. The SNP detection module then interfaces, either physically or wirelessly, to our network and applications software via our global bio-informatics IT infrastructure. Companies and consumers, using their respective virtual private networks (VPNs), via our BIO Centers infrastructure will be able to:
- access test results in a timely fashion
- rapidly develop, distribute, and support software applications
- securely build, access, or expand large databases
- provide genomic information to end users
All with a greatly reduced total cost of investment and ownership.